title: Impaired erythropoietin response to anemia in patients with lymphocytic malignancies.
authors.affiliation: Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730. hanbing_li@sina.com.cn
authors.forename: Bing
authors.initials: B
authors.lastname: Han
authors.forename: Yuan-kai
authors.initials: YK
authors.lastname: Shi
authors.forename: Jun
authors.initials: J
authors.lastname: Zhu
authors.forename: Xiao-hui
authors.initials: XH
authors.lastname: He
authors.forename: Ning-jing
authors.initials: NJ
authors.lastname: Lin
authors.forename: Shu-lan
authors.initials: SL
authors.lastname: Li
authors.forename: Ti
authors.initials: T
authors.lastname: Shen
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000740:Anemia / Q000188:drug therapy*; D004797:Enzyme-Linked Immunosorbent Assay; D004921:Erythropoietin / Q000097:blood / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000150:complications*; D008228:Lymphoma, Non-Hodgkin / Q000150:complications*; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000150:complications*
chemical_list: D004921:Erythropoietin